Twin Peaks Wealth Advisors LLC acquired a new position in Doximity, Inc. (NASDAQ:DOCS – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 20,011 shares of the company’s stock, valued at approximately $872,000.
A number of other large investors have also recently added to or reduced their stakes in DOCS. GAMMA Investing LLC increased its stake in shares of Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after purchasing an additional 412 shares in the last quarter. Van ECK Associates Corp grew its holdings in shares of Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after buying an additional 427 shares in the last quarter. Cornercap Investment Counsel Inc. lifted its stake in shares of Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after buying an additional 537 shares during the period. Arizona State Retirement System lifted its stake in shares of Doximity by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 30,779 shares of the company’s stock worth $861,000 after purchasing an additional 725 shares during the period. Finally, First Horizon Advisors Inc. boosted its stake in Doximity by 80.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock worth $48,000 after buying an additional 760 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
DOCS has been the subject of a number of research analyst reports. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research report on Friday, August 9th. Robert W. Baird increased their target price on Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, September 17th. JPMorgan Chase & Co. boosted their price objective on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research report on Monday, August 19th. Wells Fargo & Company lowered Doximity from an “equal weight” rating to an “underweight” rating and dropped their target price for the stock from $27.00 to $19.00 in a research report on Thursday, July 18th. Finally, Morgan Stanley lifted their price target on Doximity from $25.00 to $26.00 and gave the company an “underweight” rating in a report on Friday, August 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Doximity currently has an average rating of “Hold” and an average price target of $35.83.
Insider Activity
In other Doximity news, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $35.00, for a total value of $1,050,000.00. Following the completion of the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at $10,836,945. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $28.18, for a total value of $70,450.00. Following the transaction, the director now owns 10,258 shares of the company’s stock, valued at $289,070.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,511 shares of company stock worth $1,146,271 in the last three months. 37.40% of the stock is owned by insiders.
Doximity Trading Up 0.8 %
NASDAQ:DOCS traded up $0.34 on Wednesday, hitting $42.22. 65,093 shares of the company’s stock traded hands, compared to its average volume of 1,667,410. The firm has a 50-day moving average price of $40.32 and a 200-day moving average price of $32.08. The company has a market cap of $7.84 billion, a PE ratio of 52.45, a price-to-earnings-growth ratio of 5.29 and a beta of 1.29. Doximity, Inc. has a 1 year low of $19.89 and a 1 year high of $44.88.
Doximity (NASDAQ:DOCS – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.06. The company had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. On average, research analysts forecast that Doximity, Inc. will post 0.8 EPS for the current fiscal year.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories
- Five stocks we like better than Doximity
- What is a Low P/E Ratio and What Does it Tell Investors?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Profitably Trade Stocks at 52-Week Highs
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- What is the Euro STOXX 50 Index?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.